Litewave.AI, Inc — SEC Form D Filing

Litewave.AI, Inc filed an SEC Form D on May 27, 2026, reporting $1.48M raised in Artificial Intelligence.

Form D filing details

Filing
SEC Form D
Filing date
May 27, 2026
Amount reported
$1.48M
Round stage
Seed
Industry
Artificial Intelligence
Website
https://litewave.ai/

What the company does

Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Pharmaceutical manufacturers face challenges in digitizing operations and managing compliance risks.

Solution

Litewave AI provides deploy-anywhere AI agents to unify data, validate records, and enable real-time decision-making.

Why now

The demand for efficient manufacturing processes and compliance in the pharmaceutical industry is increasing.

Verdict

This cleared because investors recognized a pressing need for digital transformation in pharmaceutical operations, not because Litewave AI offered a uniquely revolutionary solution. The implicit bet was on the growing urgency for compliance and efficiency in the sector, suggesting a market ripe for innovation. However, the limited upside lies in the competitive landscape, where established players and their solutions can quickly overshadow newcomers, reducing durability of the business.

Source: SEC EDGAR Form D filing